PURE Bioscience Raises $555,000 in Private Share Placement

• PURE Bioscience raised $555,000 in a private placement that closed on October 15, 2026.
• The financing involved 10,183,486 unregistered common shares priced at $0.0545 each.
• Director Tom Y. Lee invested the full $555,000 directly and through affiliates.
• Expected net proceeds of approximately $555,000 will fund general corporate purposes, including research and development, administrative expenses and working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PURE Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047762), on October 20, 2026, and is solely responsible for the information contained therein.